CDKN2A and neoplasm: Mutations and deletions of CDKN2A were independently associated with advanced tumour stage in our cohort and some investigators have associated CDKN2A copy number loss with poor prognosis in HNSCC [59], which was also observed in univariate analysis in our patients.